![]() GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | ||
Founding Date | Founding Date 2003 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ | Locations Alameda, US HQ |
Employees | Employees 5025% increase | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 8.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Net income | Net income ($153.9m) (FY, 2025) | Net income $782.6m (FY, 2025) |

Exelixis is an oncology company that develops cancer treatments.
View company